<--- Back to Details
First PageDocument Content
Biology / Protease inhibitors / Cytokines / Boceprevir / Ribavirin / Peginterferon alfa-2a / Interferon / Hepatitis / Hepatitis C / Antivirals / Medicine / Pharmacology
Date: 2014-10-01 21:56:22
Biology
Protease inhibitors
Cytokines
Boceprevir
Ribavirin
Peginterferon alfa-2a
Interferon
Hepatitis
Hepatitis C
Antivirals
Medicine
Pharmacology

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 35,71 KB

Share Document on Facebook

Similar Documents

Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

DocID: 1vngt - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

DocID: 1vjI2 - View Document

APASL and CEVHAP Partnership: a Hepatitis-Free World November

DocID: 1vgwC - View Document

California Institute of Technology Hepatitis B Vaccination Offer Form Occupational Exposure to Bloodborne Pathogens Please complete this form if you may come in contact with human blood or other potentially infectious hu

DocID: 1vf93 - View Document